A Study of Virtual Reality and Linaclotide for IBS-C | MicrobiomeTrials← Back to trialsNCT05796388
A Study of Virtual Reality and Linaclotide for IBS-C
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-05-31Est. Completion: 2026-10
Enrollment target: 65 participants Locations- Mayo Clinic Florida, Jacksonville, Florida, United States
Other microbiome trials you might be interested in
ConstipationProbioticProbiotic Intervention
Constipation is a prevalent gastrointestinal condition. Beyond simple lifestyle measures (e.g. increasing fibre intake, …
London, United KingdomCompleted Jul 20, 2026
ConstipationIrritable Bowel Disease
This cross-sectional, observational, controlled comparative study aims to investigate the relationship between interocep…
Istanbul, Turkey (Türkiye)Est. completion Mar 31, 2027
Phase 1
Recruiting
Irritable Bowel Syndrome (IBS)Microbiome
This study is intended to characterize longitudinal changes in the small intestinal microbiome following rifaximin treat…
Calgary, CanadaEst. completion Dec 2027